 |
|
Diurnal Intraocular Pressure with Bimatoprost/Timolol Fixed Combination versus Latanoprost/Timolol Fixed Combination in Healthy Subjects
Seong Hee Shim, Joon Mo Kim, Chul Young Choi, Chan Yun Kim
Korean J Ophthalmol. 2014;28(1):39-48. Published online 2014 Jan 21 DOI: https://doi.org/10.3341/kjo.2014.28.1.39
|
|
Citations to this article as recorded by
 Efficacy and Safety of a Fixed Combination of Bimatoprost (0.03% w/v) and Timolol (0.5% w/v) for Patients with Open-angle Glaucoma
Jae Jin Cho, Jae Yeun Lee
Journal of the Korean Ophthalmological Society.2023; 64(3): 232. CrossRef A randomized clinical trial comparing three fixed combinations of bimatoprost with timolol in patients with open-angle glaucoma or ocular hypertension
Ewa Mrukwa-Kominek, Marta Misiuk-Hojlo, Adrienne Csutak, Ingeborg Stalmans, Gerhard Garhofer
Current Medical Research and Opinion.2023; 39(5): 775. CrossRef On the optimal values of «target» intraocular pressure
M. D. Kats, A. V. Kuroyedov
National Journal glaucoma.2022; 21(3): 72. CrossRef Topical Medication Therapy for Glaucoma and Ocular Hypertension
Tao Wang, Linlin Cao, Qikun Jiang, Tianhong Zhang
Frontiers in Pharmacology.2021;[Epub] CrossRef Review of the measurement and management of 24-hour intraocular pressure in patients with glaucoma
Kaweh Mansouri, Angelo P. Tanna, Carlos Gustavo De Moraes, Andrew S. Camp, Robert N. Weinreb
Survey of Ophthalmology.2020; 65(2): 171. CrossRef Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5 % timolol in normal-tension glaucoma patients
Joon Mo Kim, Tae-Woo Kim, Chan Yun Kim, Hwang Ki Kim, Ki Ho Park
Japanese Journal of Ophthalmology.2016; 60(1): 20. CrossRef
|